Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
Date Range: 

 Consort MedicalEkf DiagnosticsImmunodiagnostic SystemsTheralase TechnologiesIntelligent Ultrasound Group
Price Information
Current PriceGBX 758GBX 33.25GBX 290C$0.21GBX 10
52 Week RangeBuyN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price TargetGBX 1,172.50N/AN/AN/AN/A
% Upside from Price Target54.68% upsideN/AN/AN/AN/A
Trade Information
Market Cap£374.18 million£150.99 million£83.47 millionC$42.80 million£22 million
Average Volume23,005206,8061,203527,65713,886
Sales & Book Value
Annual Revenue£305.10 million£43.62 million£38.51 millionC$1.19 million£5.91 million
Price / Sales1.233.462.1735.853.72
CashflowGBX 29.28 per shareGBX 2.81 per shareGBX 96.10 per shareC$0.01 per shareGBX 2.20 per share
Price / Cash25.8911.843.0235.004.55
Book ValueGBX 485.40 per shareGBX 14.60 per shareGBX 191.80 per shareC$0.02 per shareGBX 4.70 per share
Price / Book0.020.020.0212.350.02
Net IncomeN/AN/AN/AN/AN/A
EPSGBX 21.20GBX 2.30GBX 2.70C($0.03)GBX (2.70)
Trailing P/E Ratio35.7514.46107.41N/AN/A
Forward P/E Ratio
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutGBX 0.28N/AGBX 0.01C$3.09N/A
Dividend Yield0.04%N/A0.00%1,471.43%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio1.32%N/A0.37%N/A N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio46.56%2.67%2.12%6.60%N/A
Current Ratio1.63%1.81%6.50%2.52%3.68%
Quick Ratio1.04%1.34%5.37%1.59%3.40%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding49.36 million454.09 million28.78 million203.81 million220.00 million
Next Earnings DateN/AN/AN/A12/5/2019 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
 Consort MedicalEkf DiagnosticsImmunodiagnostic SystemsTheralase TechnologiesIntelligent Ultrasound Group

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel